Literature DB >> 34219243

Bradyarrhythmias in patients with SARS-CoV-2 infection: A narrative review and a clinical report.

Maria Chiara Gatto1, Alessandro Persi1, Marzia Tung1, Rosa Masi1, Stefano Canitano1, Amir Kol1.   

Abstract

Several cardiovascular diseases and arrhythmic disorders have been described in COVID-19 era as likely related to SARS-CoV-2 infection. The prognostic relevance of bradyarrhythmias during the infection has not been yet described and no data are available about long-term heart conduction disorders. A review of literature concerning the association between hypokinetic arrhythmias and COVID-19 from January 2020 to February 2021 was performed. The key-words used for the research were: "sinus node disfunction," "sick sinus syndrome (SSS)," "sino-atrial block," "atrio-ventricular block (AVB)," "bradyarrhythmias," and "COVID-19″ or "SARS-CoV-2.″ Excluding "relative bradycardia," a total of 38 cases of bradyarrhythmia related to SARS-CoV-2 infection have been described, even in very young people, requiring in many cases a definitive pacemaker implantation. Furthermore, we report a case of non-hospitalized 47-years old man with a SSS developed as a consequence of mild SARS-CoV-2 infection. While in all described cases heart conduction disorders were found at presentation of the infection or during hospitalization for COVID-19, in our case the diagnosis of SSS was made after the resolution of the infection. Although rarely, heart conduction disorders may occur during COVID-19 and the present case highlights that a cardiological follow up may be desirable even after the resolution of infection, especially in the presence of symptoms suggesting a possible heart involvement.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  SARS-CoV-2; atrio-ventricular block; heart conduction disorders; sick sinus syndrome; sinus node dysfunction

Year:  2021        PMID: 34219243     DOI: 10.1111/pace.14308

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  6 in total

1.  Prognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19.

Authors:  Giulia Savelloni; Maria Chiara Gatto; Francesca Cancelli; Anna Barbetti; Francesco Cogliati Dezza; Cristiana Franchi; Martina Carnevalini; Gioacchino Galardo; Tommaso Bucci; Maria Alessandroni; Francesco Pugliese; Claudio Maria Mastroianni; Alessandra Oliva
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

2.  COVID-19 and Bradyarrhythmias: A Case Report With Literature Review.

Authors:  Saad Ali Ansari; Yusra Ansari; Tahir Muhammad Abdullah Khan
Journal:  Cureus       Date:  2022-01-24

3.  Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation.

Authors:  G Ceccarini; D Gilio; S Magno; C Pelosini; M Leverone; C Miceli; A Barison; I Fabiani; M Emdin; F Santini
Journal:  J Endocrinol Invest       Date:  2022-04-06       Impact factor: 5.467

Review 4.  Characteristics of bradyarrhythmia in patients with COVID-19: Systematic scoping review.

Authors:  Todd Nagamine; Sandeep Randhawa; Yoshito Nishimura; Ricky Huang; Thiratest Leesutipornchai; Kevin Benavente; Stephanie Yoshimura; James Zhang; Chanavuth Kanitsorphan
Journal:  Pacing Clin Electrophysiol       Date:  2022-03-03       Impact factor: 1.912

Review 5.  COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19.

Authors:  Tzuriel Sapir; Zaelig Averch; Brian Lerman; Abraham Bodzin; Yeshaya Fishman; Radhashree Maitra
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

6.  Bradycardia and Heart Rate Fluctuation Are Associated with a Prolonged Intensive Care Unit Stay in Patients with Severe COVID-19.

Authors:  Pattraporn Tajarernmuang; Konlawij Trongtrakul; Warawut Chaiwong; Teerapat Nantsupawat; Athavudh Deesomchok; Panida Chanayat; Nutchanok Niyatiwatchanchai; Theerakorn Theerakittikul; Atikun Limsukon; Chaicharn Pothirat; Chalerm Liwsrisakun; Chaiwat Bumroongkit
Journal:  Medicina (Kaunas)       Date:  2022-07-19       Impact factor: 2.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.